Follow-up of thrombophilia, inflammation and markers of cardiovascular disease of HIV-1 patients on longterm cART

Follow-up of thrombophilia, inflammation and markers of cardiovascular disease of HIV-1 patients on longterm cART - INF-BEAST2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47997

Enrollment

Registered

2019-06-26

Start date

2019-07-15

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acquired thrombophilia clotting disoder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participation in the INF-BEAST study

Exclusion criteria

Exclusion criteria: No informed consent provided for participation in INF-BEAST2

Design outcomes

Primary

Measure	Time frame
Plasma-levels of anti-thrombin, protein C antigen, protein S antigen, free protein S, fibrinogen, lupus anticoagulans, von Willebrand factor antigen, D-dimer	—

Secondary

Measure	Time frame
hsCRP, CRP, cholesterol, HDL-, LDL-cholesterol, triglycerides and the occurrence of venous thrombosis and cardiovascular events after almost 8 years of cART.	—

Countries

Netherlands

Outcome results